- Title
-
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study
- Authors
- Dicitore, A., Gaudenzi, G., Carra, S., Cantone, M.C., Oldani, M., Saronni, D., Borghi, M.O., Grotteschi, J., Persani, L., Vitale, G.
- Source
- Full text @ Cancers
Effects of AXI on cell viability after 6 days of treatment. Dose response curves were generated after MTT (for NCI-H727 and UMC-11) or MTS (for NCI-H835 and NCI-H720) assays and are expressed as nonlinear regression (curve fit) of log (concentration drug) versus the percentage of vehicle control (CTR). Values represent the mean and S.E.M. of at least three independent experiments. * |
AXI modulation of cell cycle in NCI-H727 ( |
AXI perturbation of cell death in NCI-H727 ( |
Representative Western blot images ( |
Effects of AXI treatments on tumor-induced angiogenesis in zebrafish embryos implanted with lung carcinoid cells. Representative epifluorescence images of |
Effects of AXI on invasiveness of human LC cells in grafted zebrafish embryos. Quantification of cell spread in the tail of embryos injected with NCI-H727 ( |
Effects of AXI incubation on the production of pro-angiogenic growth factors in human LC cell lines. VEGF ( |